The largest database of trusted experimental protocols
> Procedures > Health Care Activity > Weight Reduction Programs

Weight Reduction Programs

Discover weight reduction programs that optimize your weight loss journey.
Our AI-powered platform scans scientific literature, preprints, and patents to locate the most reproducible and accurate protocols.
Compare multiple strategies and products side-by-side, identifying the best approches for your weight loss needs.
Get the edge in your weight reduction reasearch with PubComapre.ai.

Most cited protocols related to «Weight Reduction Programs»

The Longitudinal Assessment of Bariatric Surgery-2 is a ten center observational cohort study of 2458 adults undergoing an initial Roux-en-Y gastric bypass (RYGB), laparoscopic adjustable gastric band (LAGB), or other bariatric procedure.6 This report utilizes data collected between April 2010 and November 2012 at annual assessments 1 to 5 years after RYGB or LAGB. Each center had institutional review board approval and all participants provided written informed consent.
Annually, participants were asked to report on mailed questionnaires two postoperative weights and the dates weights were measured: (1) weight from last medical office or weight loss program visit (self-reported medical weight) and (2) last self-weighing (self-reported personal weight). Self-reported weights could be from any scale with or without shoes or bulky clothing. Using standardized data collection protocols, study personnel measured height before surgery using a stadiometer and measured weights before surgery and annually afterwards on a standard scale (Tanita® Body Composition Analyzer, model TBF-310) without shoes and bulky clothing (measured weight).
Participants with postoperative measured weights and self-reported weights from no more than 30 days before the measured weight were included. If both self-reported weights met this criterion then both were included. If participants had self-reported and measured weights meeting this criterion at multiple time points, weights from one randomly selected time point were used.
Statistical significance of weight differences was assessed using t-tests for each type of self-reported weight and normal mixed models for all self-reported weights combined. Analyses were conducted using SAS (version 9.2). Two-sided P-values less than 0.05 are considered statistically significant.
Publication 2013
Adult Bariatric Surgery Body Composition Dietary Fiber Ethics Committees, Research Gastrojejunostomy Laparoscopy Operative Surgical Procedures Stomach Weight Reduction Programs
At randomization, all participants were given a self-help behavioral-treatment booklet with instructions for improving bladder control.17 The booklet provided basic information about incontinence, how to locate pelvic-floor muscles and how to perform daily exercises with them, how to use pelvic-floor muscles to avoid stress incontinence, and how to control urinary urgency, as well as instructions on completing voiding diaries. Incontinence was not discussed further in either the control group or the weight-loss group.
Women assigned to the control group were scheduled to participate in four education sessions at months 1, 2, 3, and 4. During these 1-hour group sessions, which included 10 to 15 women, general information was presented about weight loss, physical activity, and healthful eating habits, according to a structured protocol.
The weight-loss program was designed to produce an average loss of 7 to 9% of initial body weight within the first 6 months of the program and was modeled after that used in the following two large clinical trials: Look AHEAD (Action for Health in Diabetes),18 (link),19 (link) a lifestyle intervention trial intended to achieve and maintain weight loss in patients with diabetes, and the Diabetes Prevention Program.20 (link) The participants in the weight-loss program met weekly for 6 months in groups of 10 to 15 for 1-hour sessions that were led by experts in nutrition, exercise, and behavior change and were based on a structured protocol. The participants were given a standard reduced-calorie diet (1200 to 1500 kcal per day), with a goal of providing no more than 30% of the calories from fat. To improve adherence, the participants were provided with sample meal plans and were given vouchers for a meal-replacement product (Slim-Fast) to be used for two meals a day during months 1 to 4 and for one meal a day thereafter.
The participants were encouraged to gradually increase physical activity (brisk walking or activities of similar intensity) until they were active for at least 200 minutes each week. Behavioral skills, including self-monitoring, stimulus control, and problem-solving, were emphasized.
Publication 2009
Behavior Therapy Body Weight Diabetes Mellitus Diet Infantile Neuroaxonal Dystrophy Muscle Tissue Patients Pelvic Diaphragm Preventive Health Programs Urinary Bladder Urinary Stress Incontinence Urine Weight Reduction Programs Woman
The sample size was selected to provide a statistical power of .80 to detect a 2.5% difference in weight regain between groups (two-tailed testing with Bonferroni adjustments). We used a replicated Latin square design with county and session time serving as factors.
The data were analyzed using SAS software.29 Preliminary analyses revealed that a greater number of black women were randomized to the telephone group (P =0.04). There were no other significant differences among conditions in baseline characteristics (Table 1) or in changes in weight and other outcomes following the initial weight-loss program (Table 2). Three missing-not-at-random (MNAR) approaches were used to examine the data. Differences in weight and secondary outcomes between 6 and 18 months were analyzed using pattern mixture models.30 For each treatment group, we computed
P*+(1P)*(Y_18Y_6for completers)
where P is the proportion that did not complete extended care, (Y_18-Y_6) is the estimated difference in means for the completers, and Δ is a sensitivity parameter that corresponds to the difference in means for the study non-completers. Different values of Δ correspond to common missing data assumptions for participants who were lost to follow-up:

Δ = 3.6 corresponds to regaining 0.3 kg/month after leaving the study,

Δ = (Y_0 – Y_6) corresponds to returning to baseline weight, where Y_0 is the baseline weight and Y_6 is the weight after initial treatment (at 6 months), and

Δ = 0 corresponds to weight staying constant after Month 6.

The first scenario is based on the documented pattern of weight regain following lifestyle treatment.13 (link),26 (link),27 (link) The second scenario assumes a return to baseline values for participants lost to follow-up.24 (link),31 (link) The third scenario is based on the less conservative but commonly used “last observation carried forward” approach,31 (link) which assumes that participants lost to follow-up have fully maintained the progress observed at their last assessment visit. Because there is no consensus on the approach to missing data in weight-loss studies,31 (link) we examined the data using three MNAR scenarios. However, all three approaches revealed the same pattern of significant findings. Because the rate of weight regain following lifestyle treatment has been well documented, we present the weight change outcomes according to the first scenario. Changes in cardiovascular risk factors during the year following lifestyle treatment are less well known; therefore, we present those outcomes according to the second scenario.
Finally, we fit linear regression models with treatment and adherence as covariates to test the hypothesis that adherence served as a mediator32 of the relationship between extended care and weight change from month 6 to 18.
Publication 2008
Hypersensitivity Long-Term Care Weight Reduction Programs Woman
We generated a list of 141 commercial and proprietary weight loss programs through several sources: obesity experts, U.S. News and World Report rankings, and Internet searches (Google, Bing)(Supplemental Table 1). Using information provided on the programs’ websites, we characterized each program with respect to weight loss focus, dietary change, meal replacements, physical activity, behavioral/social support (e.g., coaching, online forum), delivery location (e.g., residential, online), medication/supplement use, and availability in the U.S. (information available from authors upon request).
We included programs that emphasized nutrition (dietary change and/or meal replacements) and behavioral counseling/social support components with or without physical activity, as dietary change and support are essential components in effective weight loss programs (15 (link)). We excluded programs that 1) did not focus on weight loss (e.g., wellness, food addiction), 2) promoted medications/supplements, 3) were not currently available across the U.S., or 4) were residential programs. Thirty-two commercial or proprietary weight loss programs met our criteria.
Publication 2015
Diet Dietary Supplements Food Addiction Obesity Obstetric Delivery Pharmaceutical Preparations Surgical Replantation Weight Reduction Programs
The target population for the NEW study included postmenopausal women from the greater Seattle, WA area, aged 50–75 years, who were overweight or obese (body mass index (BMI) ≥25 kg/m2, or ≥23 kg/m2 for Asian-American women), and exercising <100 min/week at moderate intensity or greater. Specific exclusion criteria included: diagnosed diabetes, fasting blood glucose ≥126 mg/dL, or use of diabetes medications; use of postmenopausal hormone therapy within the prior 3 months; history of breast cancer or other serious medical condition(s); alcohol intake in excess of 2 drinks/day or current smoker; contraindication to participating in the diet or exercise intervention for any reason, including an abnormal exercise tolerance test, current or planned participation in another structured weight loss program, use of weight loss medications, or additional factors that might interfere with measurement of outcomes or with the success of the intervention (e.g. inability to attend facility-based sessions).
Women were recruited through targeted mass mailing campaigns and media publicity or community outreach (Figure 1). Invitation letters were sent to 126,802 age-eligible women and 5,621 responded; in addition we received 2,048 media and community outreach-prompted calls. 929 women were telephone screen-eligible, a total of 703 women attended the information session, 684 women were screened in clinic, and 439 were randomized into the study (approximately 80% from mass mailings, 20% from media and community outreach).
Publication 2011
Asian Americans Blood Glucose Diabetes Mellitus Diet Exercise Tests Hormones Index, Body Mass Malignant Neoplasm of Breast Obesity Pharmaceutical Preparations Target Population Therapeutics Weight Reduction Programs Woman

Most recents protocols related to «Weight Reduction Programs»

The study included 168 obese women (BMI ≥ 30 kg/m2) with BED or subthreshold BED, aged 18–68 years (M = 41, SD = 12.6), who were referred between 2014 and 2017 for CBT to Novarum, a specialist treatment centre for obesity and eating disorders in Amsterdam, the Netherlands.
Diagnostic assessment included an initial telephone screening on eating disorder symptoms and other psychiatric symptoms and, if applicable, retrievement of information about former psychological treatments. Subsequently, a clinical interview by either a licensed and trained psychologist or psychiatrist was conducted, in which the presence of BED or subthreshold BED was determined, as well as relevant psychiatric comorbidity. The assessment for eating disorders included a semi-structured diagnostic interview based on the SCID-I eating disorder module as part of the Structured Clinical Interview for DSM-IV, Patient Edition (SCID-P) [42 ] including specific questions regarding criteria for binge eating as established in the Eating Disorder Examination (EDE) interview [43 ]. The diagnostic formulation and proposed treatment options were then confirmed by a multidisciplinary team. As DSM-5 was introduced in the Netherlands on January 2017, the former DSM-IV diagnosis of all participants were revised (by the psychiatrist of the research team) using the DSM-5 criteria for BED and subthreshold BED (as described by the DSM-5 category Other Specified Feeding and Eating Disorders (OSFED)).
Patients engaging in compensatory bulimic behaviors like vomiting or laxative misuse were not eligible for this study, nor were patients who were currently in concurrent treatment for BED or weight loss programs. Other exclusion criteria were severe comorbid psychiatric disorders (e.g. psychotic disorders, severe mood disorders, suicidality or substance use disorders), mental retardation and current pregnancy.
A total of 168 patients participated in the study, 156 of which completed their treatment program. 12 patients dropped out of treatment because of current life events, patient’s feeling that either the therapy did not meet their expectation in relief from complaints or the unilateral belief that she had already improved sufficiently. In some cases, the therapist thought a comorbid disorder required attention first. Of the 156 treatment completers, 7 patients were excluded from analysis due to missing data on one of the primary outcome variables, the EDE-Q global score or EDE-Q self-reported binge eating frequency. Remaining patients with normative EDE-Q global scores both at admission and discharge (n = 9) were not included in the analyses since improvement for this group was not applicable, leaving 140 patients for further analyses.
This study protocol was approved by the Medical Ethical Review Committee (METC) of the Amsterdam Medical Centre (AMC). All participants gave informed written consent before enrolment and received 15 euro compensation for their willing participation.
Full text: Click here
Publication 2023
Attention Diagnosis Eating Disorders Ethical Review Intellectual Disability Laxatives Mental Disorders Mood Disorders Obesity Patient Discharge Patients Pregnancy Psychiatrist Psychologist Psychotic Disorders SCID Mice Substance Use Disorders Weight Reduction Programs Woman
Individuals who were actively participating in a larger, randomized trial through a hospital-based research center which included an internet-delivered behavioral weight loss program, were recruited for the current qualitative study via an email invitation. Participants were recruited from the first 3 cohorts and had been enrolled for 4, 7, or 11 months. The purpose of the larger randomized clinical trial was to examine whether providing brief or extended phone coaching to those with sub-optimal early weight loss during the internet-delivered program improved weight loss outcomes. All participants received a 12-month internet-delivered program and were given a 10% weight loss goal. To facilitate this weight loss, participants were given a calorie intake goal between 1200 and 1800 kcal/day, asked to self-monitor daily caloric intake and encouraged to engage in 150 min/week of moderate-intensity physical activity. Computer-generated feedback based on self-monitoring data was provided and video lessons were available on the website which covered topics such healthy eating, physical activity, and behavioral strategies. The study eligibility criteria for the weight loss program has been published previously, (Unick et al., 2020 (link)) but in short, participants were 18–70 years old with a baseline body mass index between 25 and 45 kg/m2 and resided in Rhode Island or Massachusetts.
Full text: Click here
Publication 2023
Eligibility Determination Index, Body Mass Weight Reduction Programs
At screening (at least 5 months before baseline from September 2020 to February 2021), an independent nurse contacted the participants for eligibility by gathering phone call data about their age, health information, and medical history (such as smoking status, comorbidities, and weight loss program participation for the last 6 months).
Study interviews: The eligible participants met in the lab after an overnight fast for at least 12 h at both baseline and post-intervention testing. Demographic data (age, gender, height, weight, waist-hip ratio (WHR), and BMI) and laboratory test data were collected.
The participants had a light breakfast at least two hours before undergoing a submaximal exercise test under the supervision of a well-trained research member (M.M) to determine the proper individualized exercise intensity. Participants returned within a week after all eligibility criteria were confirmed to begin their program. The same protocol was used for the three-month follow-up, which ended for all participants on October 30, 2021, while the entire study was completed on January 30, 2022.
Full text: Click here
Publication 2023
Eligibility Determination Gender Light Nurses Supervision Waist-Hip Ratio Weight Reduction Programs

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Adult Bariatric Surgery Blood Vessel Body Composition Cancer of Liver Celiac Disease Crohn Disease Diabetes Mellitus, Non-Insulin-Dependent Dietary Supplements Disease, Chronic Hepatobiliary Disorder High Blood Pressures Hispanic or Latino Index, Body Mass Inflammatory Bowel Diseases Metabolic Diseases Pharmaceutical Preparations Syndrome Ulcerative Colitis Weight Reduction Programs Woman
This was a cross-sectional study in which the vitamin D intake of participants was estimated using the method of triads that combine three assessment methods: FFQ, 7d-FR and vitamin D serum biomarker. The study process is represented in Figure 1. Healthy women of reproductive age (18–45 years) living in Meknes province and surrounding areas were recruited throuμgh an announcement at Moulay Ismail university population. The latitude of the chosen study area is around 33.89° which make vitamin D skin synthesis possible across 300/364 days of the year [43 (link)]. Therefore, participant recruitment was performed between March and April 2019, in early spring season, when UVB strength would probably be moderate.
The literature identifies a sample size of 100 individuals as a quality criterion for validation studies [44 (link)]. A minimum of 50 subjects is indicated when using biomarkers as a reference method [44 (link),45 (link)]. Similarly, for applying the Bland Altman approach, at least 50 is preferable to evaluate the limits of agreement [28 (link)]. Since 189 participants replied to our invitation voluntarily and were enrolled in the present study, the sample size was then considered as satisfactory. Exclusion criteria for the study were: women involved in loss weight programs, diet restriction (i.e., veganism or vegetarianism, lactose intolerance), or under medication known to interfere with vitamin D metabolism, such as glucocorticoids, carbamazepine used to treat epilepsy or Cholesterol-lowering druμgs, statin [46 (link)]. Furthermore, pregnant or breast-feeding women and women with self-reported medical conditions were excluded (i.e., severe anemia, hemophilic syndrome and malabsorption syndromes that may cause decreased vitamin D) [47 (link)].
All participants were invited to attend two appointments for data collection.
In visit 1: All participants were informed about the study process and the data collection. Next, inclusion/exclusion criteria were verified. Screening identified 167 women of reproductive age eligible and agreed to participate in the study. Afterwards, participants were divided into four groups and a dietitian explained and administered the ViD-FFQ and 7d-FR to each group. However, food record brochures that included written instructions and examples were provided individually to complete at home. The participants were asked to complete the VitD-FFQ and then the 7d-FR the following week to avoid memory bias between the dietary assessments. In order to reduce the social desirability bias, it was clearly explained to all participants that the aim of the study was nothing more than the evaluation of the VitD-FFQ as opposed to their food habits.
In visit 2: One week later, another visit was organized, and all VitD-FFQs and the 7d-FR were reviewed upon completion and submission by the same dietitian as the first visit. We only included the participants who fully completed and returned their 7d-FR. Incomplete FFQs and FR were excluded (i.e., missing items or day, an unreported quantity of food product and portion sizes consumed and others). In addition, blood samples and anthropometric measurements were taken by two registered nurses. All participants were interviewed to evaluate their sun exposure score during the last month using the sun exposure questionnaire (SEQ). The demographic information, such as the age and socioeconomic status of all participants, was also collected using a general questionnaire.
A total of 154 VitD-FFQs and the associated 7-FRs were of good quality of completeness. However, two participants failed to provide a blood sample. Therefore, the total number of women included in the analysis was 152. The ethics committee of biomedical research at Moulay Ismail University (reference; N°1/CERB-UMI/19) approved the study protocol, and all investigations were conducted under the principles of the Declaration of Helsinki. All participants signed written informed consent.
Full text: Click here
Publication 2023
Anabolism Anemia Biological Markers BLOOD Carbamazepine Cholesterol Diet Dietary Restriction Dietitian Epilepsy Ergocalciferol Ethics Committees, Research Food Glucocorticoids Hydroxymethylglutaryl-CoA Reductase Inhibitors Lactose Intolerance Malabsorption Syndrome Memory Metabolism Pharmaceutical Preparations Registered Nurse Reproduction Skin Syndrome Triad resin Vegetarianism Vitamin D Weight Reduction Programs Woman

Top products related to «Weight Reduction Programs»

Sourced in United States, Poland, Germany, France, Czechia, Sweden
Statistica 12 is a comprehensive data analysis and visualization software suite developed by StatSoft. It provides a range of tools for data management, statistical analysis, and reporting.
Sourced in Denmark
The FlexPen device is a prefilled, disposable insulin pen designed for the delivery of insulin. It provides a convenient and accurate way for patients to administer their insulin dosage. The FlexPen features a dial mechanism that allows for the selection of the desired insulin dose.
Sourced in United States
The ActiGraph wGT3X is a research-grade, triaxial accelerometer device designed for objective physical activity and sleep monitoring. It measures and records physical movement in three dimensions (X, Y, Z) with high precision and resolution. The device is compact, lightweight, and water-resistant, making it suitable for a variety of research and clinical applications.
Sourced in United States, United Kingdom, Denmark, Austria
Stata is a general-purpose statistical software package for data analysis, data management, and graphics. It provides a wide range of data manipulation, statistical, and graphical tools to help researchers and analysts effectively analyze and visualize data.
Sourced in United States
SPSS 21.0 is a statistical software package developed by IBM. It is designed to analyze and visualize data, offering a wide range of statistical techniques and tools for data management, analysis, and reporting. The core function of SPSS 21.0 is to provide users with the ability to perform advanced statistical analyses, generate reports, and create customized visualizations of their data.
Sourced in United States, United Kingdom, Japan, Austria, Germany
SPSS Statistics for Windows, Version 25.0 is a software application designed for statistical analysis. It provides a comprehensive set of tools for data management, analysis, and visualization.
Sourced in Germany
The Seca model 799 is a digital scale designed for medical use. It features a large, easy-to-read display and can measure weights up to 300 kg with an accuracy of 50 g.
Sourced in Japan, United States, Israel, Germany, Australia, United Kingdom
The Digital Scale is a precision measurement device that accurately determines the weight of various objects. It utilizes advanced digital technology to provide reliable and consistent results.
Sourced in United States, Denmark, United Kingdom, Austria, Sweden
Stata 13 is a comprehensive, integrated statistical software package developed by StataCorp. It provides a wide range of data management, statistical analysis, and graphical capabilities. Stata 13 is designed to handle complex data structures and offers a variety of statistical methods for researchers and analysts.
Sourced in United States, Japan, United Kingdom, Germany, Belgium, Austria, Italy, Poland, India, Canada, Switzerland, Spain, China, Sweden, Brazil, Australia, Hong Kong
SPSS Statistics is a software package used for interactive or batched statistical analysis. It provides data access and management, analytical reporting, graphics, and modeling capabilities.

More about "Weight Reduction Programs"

Discover the latest weight loss solutions: our AI-powered platform scans scientific literature, preprints, and patents to locate the most effective and data-driven weight reduction programs.
Compare a variety of strategies and products side-by-side, including insights from Statistica 12, FlexPen devices, ActiGraph wGT3X, Stata software, SPSS 21.0 statistical package, SPSS Statistics for Windows, Version 25.0, Seca model 799, Digital scale, and Stata 13.
Identify the optimal approach for your unique weight loss needs and get the edge in your weight management research with PubComapre.ai.
Whether you're looking to shed pounds, improve your health, or optimize your fitness journey, our platform provides the tools and insights you need to succeed.
Explore a range of evidence-based weight loss protocols, from calorie-controlled diets to exercise regimens, and find the right solution to support your weight reduction goals.